Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Joins Chorus Of Concerns About Results Of GAIN Act

Bacteria

Related Content

GAIN Begins (Part 1): FDA Completes Turnaround On Antibiotic R&D

Feb 20 2013

US Antibiotic Incentives Extended To Drugs That Prevent Or Diagnose Infections

Feb 01 2018

Antibiotic Spring? Regulatory Incentives Spur Activity – And Maybe Medical Advances

Jul 12 2017

Antibiotic Development: US FDA Needs Draft Guidance On QIDP Designation, GAO Says

Mar 06 2017

Antibiotic Development: Limited Population Pathway In US Removes Barrier

Mar 29 2017

Value-Based Reimbursement For Antibiotics Gets Skeptical Reception

Nov 16 2016

Antibiotic Development: ‘Wildcard Exclusivity’ Proposal Returns

Nov 16 2016

New Report Calls For Pushing And Pulling In Global Fight Against Superbugs

Jan 24 2018

Antibiotics Pipeline Is Lively, But Sponsors Are Fragile

Jul 04 2017

Additional Topics

United States Research & Development Regulation Infectious Diseases BioPharmaceutical

More from R&D

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window